EBMT 2018 | Vaccines for the treatment of CMV in stem cell transplant recipients

Name: Vaccines for the treatment of CMV in stem cell transplant recipients
Uploaded: 2018-03-18T00:00:00.000Z
Duration: 1 min 6 s
Description: Speaking from the 2018 European Group for Blood and Marrow Transplantation (EBMT) Annual Meeting, held in Lisbon, Portugal, Genovefa Papanicolaou, MD, from Memorial Sloan Kettering Cancer Center, New York, NY, speaks about novel vaccines that are being developed for the treatment of cytomegalovirus (CMV) in cancer patients receiving stem cell transplants.

Genovefa Papanicolaou • 18 Mar 2018

EBMT 2018

General Vaccines

Speaking from the 2018 European Group for Blood and Marrow Transplantation (EBMT) Annual Meeting, held in Lisbon, Portugal, Genovefa Papanicolaou, MD, from Memorial Sloan Kettering Cancer Center, New York, NY, speaks about novel vaccines that are being developed for the treatment of cytomegalovirus (CMV) in cancer patients receiving stem cell transplants.